Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six brokerages that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and five have given a...